Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

These gene variations are not linked to alopecia areata in Egyptians.

Baricitinib shows promise for treating alopecia areata with mild side effects.

More research is needed to find the best long-term treatments for Alopecia Areata.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Lower zinc levels are linked to more severe hair loss in alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Topical corticosteroid was not more effective than placebo for children's alopecia areata, and atopy did not change treatment results.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.